Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study

INTRODUCTION: The effectiveness and safety of immune checkpoint inhibitor (ICI) monotherapy in advanced upper tract urothelial carcinoma (UTUC) is less reported. METHODS: In total, 106 consecutive advanced UTUC patients receiving ICI monotherapy were collected from nine high volume centers. Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ruopeng, Chen, Zeyu, Hong, Daoping, Jiang, Shuai, Yuan, Yichu, Cai, Xingyun, Hu, Hailong, Fu, Changde, Huang, Zhiyang, Wang, Zhenyu, Zheng, Bing, Huang, Jian, Wang, Zaoyu, Bao, Yige, Cai, Ming, Guo, Jianming, Chen, Minfeng, Wei, Qiang, Huang, Jiwei, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225242/
https://www.ncbi.nlm.nih.gov/pubmed/36952461
http://dx.doi.org/10.1002/cam4.5796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225242/
https://www.ncbi.nlm.nih.gov/pubmed/36952461
http://dx.doi.org/10.1002/cam4.5796

Ejemplares similares